Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents

Drug News and Perspectives

Volumn 21, Issue 6, 2008, Pages 307-311

  Epand, Richard M ^a   Epand, Raquel F ^a   Savage, Paul B ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CATIONIC STEROID ANTIBIOTIC 13; CERAGENIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN DEGRADATION; PROTEUS MIRABILIS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CHOLIC ACIDS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STEROIDS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS;

EID: 56249146713     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.6.1246829     Document Type: Article

References (27)

1. Zasloff, M. Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 1992, 4(1): 3-7.
2. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415(6870): 389-95.
3. Jenssen, H., Hamill, P. and Hancock, R.E. Peptide antimicrobial agents. Clin Microbiol Rev 2006, 19(3): 491-511.
4. Epand, R.M. and Vogel, H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1999, 1462(1-2): 11-28.
5. Hasper, H.E., Kramer, N.E., Smith, J.L. et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target hpid II. Science 2006, 313(5793): 1636-7.
6. Shai, Y. and Oren, Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001, 22(10): 1629-41.
7. Avrahami, D., Oren, Z. and Shai, Y. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry 2001, 40(42): 12591-603.
8. Yan, H. and Hancock, R.E. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother 2001, 45(5): 1558-60.
9. Rosenfeld, Y., Barra, D., Simmaco, M., Shai, Y. and Mangoni, M.L. A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J Biol Chem 2006, 281(39): 28565-74.
10. Som, A., Vemparala, S., Ivanov, I. and Tew, G.N. Synthetic mimics of antimicrobial peptides. Biopolymers 2008, 90(2): 83-93.
11. Blondelle, S.E., Takahashi, E., Weber, P.A. and Houghten, R.A. Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids. Antimicrob Agents Chemother 1994, 38(10): 2280-6.
12. Oh, J.E. and Lee, K.H. Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide. Bioorg Med Chem 1999, 7(12): 2985-90.
13. Porter, E.A., Weisblum, B. and Gellman, S.H. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J Am Chem Soc 2002, 124(25): 7324-330.
14. Tam, J.P., Lu, Y.A. and Yang, J.L. Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures. Biochemistry 2000, 39(24): 7159-69.
15. Gabriel, G.J. and Tew, G.N. Conformationally rigid proteomimetics: a case study in designing antimicrobial aryl oligomers. Org Biomol Chem 2008, 6(3): 417-23.
16. Radzishevsky, I., Krugliak, M., Ginsburg, H. and Mor, A. Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob Agents Chemother 2007, 51(5): 1753-59.
17. Mowery, B.P., Lee, S.E., Kissounko, D.A. et al. Mimicry of antimicrobial host-defense peptides by random copolymers. J Am Chem Soc 2007, 129(50): 15474-6.
18. Moore, K.S., Wehrli, S., Roder, H., Rogers, M., Forrest, J.N., Jr., McCrimmon, D. and Zasloff, M. Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci U S A 1993, 90(4): 1354-8.
19. Lai, X.-Z., Feng, Y., Pollard, J. et al. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res 2008, in press.
20. Chin, J.N., Rybak, M.J., Cheung, C.M. and Savage, P.B. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51(4): 1268-73.
21. Chin, J.N., Jones, R.N., Sader, H.S., Savage, P.B. and Rybak, M.J. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J Antimicrob Chemother 2008, 61(2): 365-70.
22. Ding, B., Yin, N., Liu, Y. et al. Origins of cell selectivity of cationic steroid antibiotics. J Am Chem Soc 2004, 126(42): 13642-8.
23. Bucki, R., Sostarecz, A.G., Byfield, F.J., Savage, P.B. and Janmey, P.A. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 2007, 60(3): 535-45.
24. Epand, R.F., Savage, P.B. and Epand, R.M. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins). Biochim Biophys Acta 2007, 1768(10): 2500-9.
25. Ding, B., Guan, Q., Walsh, J.P. et al. Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J Med Chem 2002, 45(3): 663-9.
26. Chung, Y.C., Su, Y.P., Chen, C.C., Jia, G., Wang, H.L., Wu, J.C., Lin, J.G. Relationship between antibacterial activity of chitosan and surface characteristics of cell wall. Acta Pharmacol Sin 2004, 25(7): 932-6.
27. Matsuzaki, K., Sugishita, K., Ishibe, N., Ueha, M., Nakata, S., Miyajima, K., Epand, R.M. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 1998, 37(34): 11856-63.